REGENERON PHARMACEUTICALS (REGN)

US75886F1075 - Common Stock

896.82  +2.83 (+0.32%)

After market: 896.82 0 (0%)

Full estimates are only available for subscribed users, you can see which data is available below.

Examples of complete estimate data are available for MSFT and AAPL.

Registered users have access to more data. Please register or login for additional estimates and surprises .

Yearly Revenue, EBIT, EBITDA and EPS Analyst Estimates
2021 2022 2023 2024 2025 2026 2027 2028 2029 2030
Revenue
YoY % growth
16.072B
89.15%		12.173B
-24.26%		13.117B
7.76%		14.205B
8.29%
EBITDA
YoY % growth
9.233B
142.16%		5.335B
-42.22%		4.654B
-12.77%		5.775B
24.08%
EBIT
YoY % growth
8.947B
150.13%		4.994B
-44.18%		4.233B
-15.23%		5.306B
25.34%
Operating Margin
55.67%41.03%32.27%37.35%
EPS
YoY % growth
71.38
125.53%		42.40
-40.60%		43.78
3.25%		45.76
4.51%

All data in USD

Quarterly Revenue, EBIT, EBITDA and EPS Analyst Estimates
Q1 / 24 Q2 / 24 Q3 / 24 Q4 / 24 Q1 / 25 Q2 / 25 Q3 / 25 Q4 / 25
EPS
Q2Q % growth		10.16
0.65%
Revenue
Q2Q % growth		3.283B
3.82%
EBITDA
Q2Q % growth		1.197B
EBIT
Q2Q % growth		1.199B
19.57%

All data in USD

Recent Earnings VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q4 2023
Q2Q % growth		 11.86
-5.57%		10.950.918.36%
Q3 2023
Q2Q % growth		 11.59
4.04%		10.930.666.01%
Q2 2023
Q2Q % growth		 10.24
4.81%		10.040.201.99%
Q1 2023
Q2Q % growth		 10.09
12.99%		9.750.343.50%
Recent Revenue VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q4 2023
Q2Q % growth		 3.434B
0.58%		3.351B83.3M2.49%
Q3 2023
Q2Q % growth		 3.363B
14.53%		3.298B64.7M1.96%
Q2 2023
Q2Q % growth		 3.158B
10.53%		3.077B81.1M2.64%
Q1 2023
Q2Q % growth		 3.162B
6.64%		3.06B102.1M3.34%
EPS and Revenue Revisions
Next Q (1 month) Next Q (3 month) Next Year (1 month) Next Year (3 month)
EPS0.4% -2.78% 0.05% 3.6%
Revenue-0.12% -0.06% 0.08% 2.88%